Lack of enhancing effects of degraded λ-carrageenan on the development of β-catenin-accumulated crypts in male DBA/2J mice initiated with azoxymethane

Cancer Letters

Volumn 238, Issue 1, 2006, Pages 69-75

  Hata, Kazuya ^a,b   Tanaka, Takuji ^c   Kohno, Hiroyuki ^c   Suzuki, Rikako ^c   Qiang, Sheng Hong ^b   Kuno, Toshiya ^b   Hirose, Yoshinobu ^b   Hara, Akira ^b   Mori, Hideki ^b  

^a Sunplanet Co Ltd   (Japan)

^b GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

catenin accumulated crypts (BCAC); Azoxymethane; Carrageenan; Mice

Indexed keywords

AZOXYMETHANE; BETA CATENIN; BIOLOGICAL MARKER; CARRAGEENAN; DRINKING WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ANIMALS; AZOXYMETHANE; BETA CATENIN; CARCINOGENS; CARRAGEENAN; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED DBA; MICE, INBRED STRAINS; PRECANCEROUS CONDITIONS; SPECIES SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA; RODENTIA;

EID: 33746909830     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.06.016     Document Type: Article

References (46)

1. Hirono I., and Carrageenan S. In: Hirono I. (Ed). Naturally Occurring Carcinogens of Plant Origin-Toxicology, Pathology and Biochemistry (1987), Amsterdam, Kodansya 121-126
2. Norton I.T., and Goodall D.M. Role of cations in the conformation of iota and kappa carrageenan. J. Chem. Soc. Faraday Trans. 1 79 (1983) 2475-2488
3. Anderson W., and Harthill J.E. Degraded and undegraded carrageenans and antipeptic activity. J. Pharm. Pharmacol. 19 (1967) 460-467
4. Fath R.B.J., Deschner E.E., Winawer S.J., and Dworkin B.M. Degraded carrageenan-induced colitis in CF1 mice. A clinical, histopathological and kinetic analysis. Digestion 29 (1984) 197-203
5. Watt J., and Marcus R. Carrageenan-induced ulceration of the large intestine in the guinea pig. Gut 12 (1971) 164-171
6. Watt J., and Marcus R. Ulcerative colitis in rabbits fed degraded carrageenan. J. Pharm. Pharmacol. 22 (1970) 130-131
7. Marcus R., and Watt J. Colonic ulceration in young rats fed degraded carrageenan. Lancet 2 (1971) 765-766
8. Benitz K.F., Golberg L., and Coulston F. Intestinal effects of carrageenans in the rhesus monkey (Macaca mulatta). Food Cosmet. Toxicol. 11 (1973) 565-575
9. Fabian R.J., Abraham R., Coulston F., and Golberg L. Carrageenan-induced squamous metaplasia of the rectal mucosa in the rat. Gastroenterology 65 (1973) 265-276
10. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 357 (2001) 539-545
11. Oda T. Viral hepatitis and hepatocellular carcinoma prevention strategy in Japan. Jpn. J. Cancer Res. 90 (1999) 1051-1060
12. Wang X.W., Hussain S.P., Huo T.I., Wu C.G., Forgues M., Hofseth L.J., Brechot C., and Harris C.C. Molecular pathogenesis of human hepatocellular carcinoma. Toxicology 181/182 (2002) 43-47
13. Ebert M.P., Schandl L., and Malfertheiner P. Helicobacter pylori infection and molecular changes in gastric carcinogenesis. J. Gastroenterol. 37 Suppl. 13 (2002) 45-49
14. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer Inst. 92 (2000) 690-698
15. Itzkowitz S.H., and Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 287 (2004) G7-G17
16. Tanaka T., Kohno H., Suzuki R., Yamada Y., Sugie S., and Mori H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci. 94 (2003) 965-973
17. H. Kohno, R. Suzuki, S. Sugie, T. Tanaka, β-Catenin mutations in a mouse model of inflammation-related colon carcinogenesis induced by 1,2-dimethylhydrazine and dextran sodium sulfate, Cancer Sci. 96 (2005) in press.
18. Tanaka T., Suzuki R., Kohno H., Sugie S., Takahashi M., and Wakabayashi K. Colonic a denocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess β-catenin gene mutations and increase immunorectivity for β-catenin, cyclooxygenase-2, and inducible nitric oxide synthase. Carcinogenesis 26 (2004) 229-238
19. Suzuki R., Kohno H., Sugie S., and Tanaka T. Sequential observations on the occurrence of preneoplastic and neoplastic lesions in mouse colon treated with azoxymethane and dextran sodium sulfate. Cancer Sci. 95 (2004) 721-727
20. R. Suzuki, H. Kohno, S. Sugie, T. Tanaka, Dose-dependent promoting effect of dextran sodium sulfate on mouse colon carcinogenesis initiated with azoxymethane, Histol. Histopathol. 19 (2004) in press.
21. Kohno H., Suzuki R., Sugie S., and Tanaka T. Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands. BMC Cancer 5 (2005) 46
22. Kim H.S., and Berstad A. Experimental colitis in animal models. Scand. J. Gastroenterol. 27 (1992) 529-537
23. Moyana T.N., and Lalonde J.M. Carrgeenan-induced intestinal injury in the rat: a model for inflammatory bowel disease. Ann. Clin. Lab. Sci. 20 (1990) 420-426
24. Ashi K.W., Inagaki T., Fujimoto Y., and Fukuda Y. Induction by degraded carrageenan of colorectal tumors in rats. Cancer Lett. 4 (1978) 171-176
25. Ishioka T., Kuwabara N., Oohashi Y., and Wakabayashi K. Induction of colorectal tumors in rats by sulfated polysaccharides. Crit. Rev. Toxicol. 17 (1987) 215-244
26. Corpet D.E., Tache S., and Preclaire M. Carrageenan given as a jelly, does not initiate, but promotes the growth of aberrant crypt foci in the rat colon. Cancer Lett. 114 (1997) 53-55
27. Tobacman J.K. Review of harmful gastrointestinal effects of carrageenan in animal experiments. Environ. Health Perspect. 109 (2001) 983-994
28. Cohen S.M., and Ito N. A critical review of the toxicological effects of carrageenan and processed eucheuma seaweed on the gastrointestinal tract. Crit. Rev. Toxicol. 32 (2002) 413-444
29. Matsumoto T., Kitano A., Oshitani N., Obata A., Hiki M., Hashimura H., Okawa K., Nagura H., and Kobayashi K. Immunoglobulin-containing cells in the colonic mucosa of rabbits with carrageenan-induced colitis. Dis. Colon Rectum 31 (1988) 723-729
30. Kitano A., Matsumoto T., Hiki M., Hashimura H., Yoshiyasu K., Okawa K., Kuwajima S., and Kobayashi K. Epithelial dysplasia of the rabbit colon induced by degraded carrageenan. Cancer Res. 46 (1986) 1374-1376
31. Trosko J.E., and Ruch R.J. Cell-cell communication in carcinogenesis. Front Biosci. 3 (1998) d208-d236
32. Yamada Y., Yoshimi N., Hirose Y., Kawabata K., Matsunaga K., Shimizu M., Hara A., and Mori H. Frequent β-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res. 60 (2000) 3223-3227
33. Min/+ mice. Cancer Res. 62 (2002) 6367-6370
34. Hirose Y., Kuno T., Yamada Y., Sakata K., Katayama M., Yoshida K., Qiao Z., Hata K., Yoshimi N., and Mori H. Azoxymethane-induced β-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis. Carcinogenesis 24 (2003) 107-111
35. Hata K., Yamada Y., Kuno T., Hirose Y., Hara A., Qiang S.H., and Mori H. Tumor formation is correlated with expression of β-catenin-accumulated crypts in azoxymethane-induced colon carcinogenesis in mice. Cancer Sci. 95 (2004) 316-320
36. Cooper H.S., Murthy S.N., Shah R.S., and Sedergran D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69 (1993) 238-249
37. Bird R.P. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett. 93 (1995) 55-71
38. Takahashi M., and Wakabayashi K. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cnacer Sci. 95 (2004) 475-480
39. Nakagama H., Ochiai M., Ubagai T., Tajima R., Fujiwara K., Sugimura T., and Nagao M. A rat colon cancer model induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, PhIP. Mutat. Res. 506/507 (2002) 137-144
40. Corpet D.E., and Tache S. Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency. Nutr. Cancer 43 (2002) 1-21
41. Yamada Y., and Mori H. Pre-cancerous lesions for colorectal cancers in rodents: a new concept. Carcinogenesis 24 (2003) 1015-1019
42. Mori H., Yamada Y., Kuno T., and Hirose Y. Aberrant crypt foci and β-catenin accumulated crypts; significance and roles for colorectal carcinogenesis. Mutat. Res. 566 (2004) 191-208
43. Weiner M.L. Toxicological properties of carrageenan. Agents Actions 32 (1991) 46-51
44. Tobacman J.K. Filament disassembly and loss of mammary myoepithelial cells after exposure to lambda-carrageenan. Cancer Res. 57 (1997) 2823-2826
45. Suzuki J., Na H.-K., Upham B.L., Chang C.-C., and Trosko J.E. 1-Carrageenan-induced inhibition of gap-junctional intercellular communication in rat liver epithelial cells. Nutr. Cancer 36 (2000) 122-128
46. Hagiwara A., Miyashita K., Nakanishi T., Sano M., Tamano S., Asai I., Nakamura M., Imaida K., Ito N., and Shirai T. Lack of tumor promoting effects of carrageenan on 1,2-dimethylhydrazine-induced colorectal carcinogenesis in male F344 rats. J. Toxicol. Pathol. 14 (2001) 37-43